Insider Transactions in Q4 2024 at Boston Scientific Corp (BSX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 07
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
132,527
-45.23%
|
$11,264,795
$85.0 P/Share
|
|
Oct 07
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
116,639
+18.24%
|
$2,449,419
$21.12 P/Share
|
|
Oct 07
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
162,777
-4.81%
|
$13,673,268
$84.63 P/Share
|
|
Oct 07
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
111,886
+3.17%
|
$1,790,176
$16.79 P/Share
|
|
Oct 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-16.73%
|
$579,589
$83.86 P/Share
|
|
Oct 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+4.91%
|
$85,260
$20.91 P/Share
|